Is UnitedHealth Stock a Buy, Sell, or Hold for July 2025?

UnitedHealth (UNH) has found itself under a harsh spotlight on Wall Street. Once a darling of defensive investors, UNH stock has been battered and bruised in 2025, tumbling nearly 40% year-to-date (YTD). Among S&P 500 Index ($SPX) constituents, it now ranks among the poorest performers, a dramatic shift for a company long considered a fortress in health insurance.

The trouble began with a disappointing earnings report earlier this year, which sparked fears of mounting costs and operational inefficiencies. Then came the one-two punch: UnitedHealth withdrew its forward guidance and announced a CEO shake-up. As if that were not enough, the U.S. Department of Justice reportedly began probing its billing practices, raising further red flags.